Menu

Blog

Feb 14, 2024

Promising new therapeutic approach for treating metastatic pancreatic cancer

Posted by in category: biotech/medical

A research paper published in Nature Cancer details new insights into the role of efferocytosis—the burying of dead cells—in pancreatic cancer that spreads to the liver.

Liver metastasis occurs in 40–50% of people with pancreatic ductal adenosarcoma (PDAC), and there are currently no effective therapies to cure patients that have .

Led by University of Liverpool’s Professor Michael Schmid and colleagues, this study found PDAC metastases to show high levels of immunosuppressive macrophages, a type of white blood cell that promotes .

Comments are closed.